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Abstract
Little is known about how human genetic variation affects the responses to environmental stimuli
in the context of complex diseases. Experimental and computational approaches were applied to
determine the effects of genetic variation on the induction of pathogen-responsive genes in human
dendritic cells. We identified 121 common genetic variants associated in cis with variation in
expression responses to E. coli lipopolysaccharide, influenza or interferon-β (IFNβ). We localized
and validated causal variants to binding sites of pathogen-activated STAT and IRF transcription
factors. We also identified a common variant in IRF7 that is associated in trans with type I
interferon induction in response to influenza infection. Our results reveal common alleles that
explain inter-individual variation in pathogen sensing and provide functional annotation for
genetic variants that alter susceptibility to inflammatory diseases.
Introduction
Susceptibility to complex diseases depends on both genetic predisposition and exposure to
environmental factors, with interactions between the two (GxE interactions) likely
contributing substantially to disease risk (1, 2). However, the extent and mechanisms by
which common human genetic variants interact with the environment remain poorly
explored and have been difficult to detect in clinical studies (1, 3). Genetic analysis of
molecular traits – such as gene expression profiles – offers a promising way to dissect the
molecular mechanisms underlying GxE interactions. Expression quantitative trait locus
(eQTL) studies have been used to map genetic variants contributing to variation in gene
expression, but have largely focused on steady state expression in humans (4, 5), thus
excluding GxE interactions. In model organisms, differences in growth conditions or
treatment with various stimuli have revealed the existence of response eQTLs (reQTLs)
(6-9), defined as QTLs associated with the change in expression after stimulation. Here, we
sought to identify reQTLs in humans, to explain the mechanism by which the environment
interacts with these variants, and to determine whether these variants are associated with
immune-mediated diseases.
We used dendritic cells (DCs) of the innate immune system as a model system for reQTL
studies, with physiological and clinical relevance. DCs play a direct role in the host
recognition of pathogens using specialized sensors that engage well-characterized signaling
and transcriptional networks. For example, bacterial lipopolysaccharide (LPS) activates two
distinct arms of the Toll-like receptor 4 (TLR4) pathway, whereas influenza infection
primarily activates the RNA-sensing Toll-like receptors (e.g., TLR3) and the RIG-I-like
receptors (e.g., RIG-I) (10). These, in turn, lead to the translocation of transcription factors
from the cytoplasm into the nucleus to induce the expression of immune genes, including
IFNβ secretion that engages the type I interferon response pathway to induce the expression
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of hundreds of anti-viral effectors. Genetic studies have associated common variants near
many genes in these pathways with risk of different inflammatory diseases (11, 12). DCs
also play a critical role in the pathologic immune responses underlying inflammatory
diseases (11-13), also reflected in recent genome-wide association studies (GWAS) of
several diseases (14-17), especially inflammatory bowel disease (14).
Results
Assessing the impact of genetic variation on pathogen-sensing in primary human DCs
We developed an integrated experimental and computational pipeline (Fig. 1A) to identify
variability in human DC responses and associate this variability with common genetic
variants. First, we optimized a high-throughput protocol to isolate primary CD14+CD16lo
monocytes from human blood samples (figs. S1A–S1F), differentiate them into monocyte-
derived dendritic cells (MoDCs), and stimulate them with three immunostimulatory agents
(Fig. 1B): E. coli lipopolysaccharide (LPS), influenza virus, or IFNβ (a cytokine induced by
LPS and influenza). Second, we collected genome-wide transcript profiles from resting and
stimulated DCs from 30 healthy individuals and computationally identified a ‘signature’ of
415 genes that would be informative of variation in the response in a larger cohort. Third,
we generated 1,598 transcriptional profiles (using an amplification-free platform suitable for
small cell numbers (18)) from DCs isolated from 534 healthy individuals (295 Caucasians,
122 African-Americans, 117 East Asians; table S1) in four states: resting, LPS-stimulated,
influenza-infected and IFNβ-stimulated. Finally, we associated expression variation with
genetic variation to identify cis- and trans-eQTLs and reQTLs, and investigated candidate
reQTLs for their mechanism of action.
Variability of pathogen-sensing responses between individuals
To assess the inter-individual variability of DC responses, we first profiled genome-wide
expression using microarrays in resting, LPS-stimulated and influenza-infected MoDCs
isolated from each of 30 healthy individuals (18 Caucasians, 6 Asians, 6 African-
Americans). We found 1,413 genes that were regulated in LPS- or influenza-treated cells
[log2(fold change) > 0.75 or < –1.5; FDR < 0.01; fig. S2A, table S2A; see table S2B–I for
enriched biological processes] at 5 hrs and 10 hrs, respectively (time points selected to have
maximal expression of induced clusters; figs. S1B and S1C).
We quantified reproducibility in these responses by recalling 12 of the 30 donors 2-9 months
after the first collection for MoDC isolations and profiling (table S1); we identified genes
whose inter-individual expression variance is significantly higher than their intra-individual
variance based on the serial replicates (taking into account known covariates including
gender, age and population and unknown ones using Surrogate Variable Analysis (SVA)
(19)). 222 of the 1,413 regulated genes (16%) showed significantly higher (FDR < 0.1)
inter- than intra-individual variability, either in their absolute expression or in the
differential expression (stimulated/baseline level) to at least one stimulus (Fig. 2A and table
S3). These results suggest that there is consistent variation in these traits that may have a
genetic basis.
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Expression profiling of a pathogen response signature
Mapping the genetic basis of inter-individual variation in pathogen responses requires
profiling of DC gene expression in a larger cohort; this poses a substantial technical
challenge given the limited numbers of primary cells and multiple stimuli. Furthermore, the
responses of DCs to virus, bacterial ligands and interferon are limited in scope, and do not
encompass the entire genome. We therefore defined a 415 gene signature set (Fig. 2B and
table S3) that could be monitored in small numbers of cells using a sensitive multiplex RNA
detection system (18), allowing us to scale up our study. The signature consisted of: (1) all
222 of 1,413 regulated genes with greater inter- than intra-individual variability in the
microarray study; (2) all 24 regulated genes exhibiting greater inter- than intra-population
variability (FDR < 0.1; table S3) in the microarray study; (3) 76 genes comprising the
known components of the TLR4, TLR3, RIG-I and IFNAR pathways (Fig. 1B) (10, 20-22);
(4) 61 regulated genes that play key roles in the DC response (e.g. IFNB1 and IFITM3)
(22-24); (5) 28 regulated genes residing in loci previously associated with autoimmune or
infectious diseases (25); and (6) 35 control genes including those that had among the lowest
inter-individual variance in the microarray profiles. This representative signature allowed us
to monitor genes with high inter-individual variability, as well as key components and
responses of the pathogen-sensing pathway.
We then generated 1,598 transcriptional profiles, using the 415-gene signature, from
MoDCs isolated from 534 healthy individuals (and 37 serially-collected replicates) in up to
four conditions: resting (528 individuals), LPS-stimulated (356), influenza-infected (342)
and IFNβ-stimulated (284) (Figs. 2C, S1E, S1F, table S1). The IFNβ stimulus allowed us to
partition genes that were induced by both LPS and influenza (cluster III) into those induced
secondary to type I IFN signaling (cluster IIIa) or by other mechanisms shared between
these bacterial and viral sensing pathways (cluster IIIb) such as NF-κB or AP-1 activation
(Figs. 2C and 1B). The signature expression profiles clustered similarly to those from the
microarray analysis (Fig. 2C and fig. S2C), and captured most of the variance in the
genome-wide profile (cross validation, >0.99 gtPCC; fig. S2D (26)), demonstrating the
utility of the signature to capture the genome-wide response.
reQTLs modulate cellular responses to pathogens
We mapped cis-eQTLs and cis-reQTLsby testing for association between common SNPs
(minor allele frequency >5%; genotyped with Illumina Human OmniExpress BeadChip) and
variation in either absolute transcript abundance (eQTL) or stimulation-induced change in
transcript abundance (reQTL) in a nearby gene (in which the transcriptional start site or stop
codon is within 1Mb of the SNP). We pooled individuals from the three human populations
together and included covariates and principal components to increase statistical power
while avoiding systematic confounders such as population structure and expression
heterogeneity. We identified 264 genes with cis-eQTLs in at least one condition
(permutation FDR < 0.05; Fig. 3A, figs. S3A–C, table S4A–D) (27). Notably, 22/264 genes
also associated with additional independent cis-eQTLs after conditioning on the top five
most significant SNPs in each cis-eQTL region (table S6 and fig. S3D) (27), reflecting the
complexity of the regulatory landscape around each gene.
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We detected 121 cis-reQTLs (Fig. 3B and table S4E–G; permutation FDR < 0.05; 91%
internal reproducibility in at least 2 human populations, table S5), the subset of genetic
variants that affect the induction of gene expression by LPS, influenza or IFNβ. Of the 121
genes with cis-reQTLs, 7 associations were found only in the influenza condition (e.g.,
IFNA21, Fig. 3C and fig. S3B; meta-analysis, P< 1×10−5, permutation FDR 0.02-0.03), 15
in both the LPS and influenza conditions (e.g., TEC; Figs. 3C and S3B), and 57 in all three
stimulation conditions (e.g. ARL5B, SLFN5, CLEC4F;Figs. 3C–3E and S3B), likely
reflecting activation of the shared IFNβ pathway. We hypothesized that causal variants
driving cis-reQTLs alter the sequence of genomic elements that respond to transcription
factors downstream of the pathogen-sensing receptors (Fig. 3F), and represent gene-by-
environment interactions.
To validate cis-reQTLs, we quantified allele-specific expression for pan-stimulation-specific
associations in heterozygote individuals (Figs. 3D and 3E). This was feasible for a gene with
an exonic SNP (CLEC4F rs2075221) that was the most significant reQTL SNP, and for a
gene with an exonic SNP (SLFN5 rs11651240) in linkage disequilibrium (LD) with the most
significant reQTL SNP (rs11867191, R2 = 0.501 CEU). As predicted, transcripts derived
from the major and minor alleles differed in expression after stimulation with LPS (SLFN5,
P< 0.001, t-test; CLEC4F, P< 0.01), influenza (SLFN5, P< 0.001; CLEC4F, P< 0.01) or
IFNβ (SLFN5, P< 0.001; CLEC4F, P< 0.001) but not at baseline (Figs. 3D and 3E).
cis-reQTLs that alter the sequence of TF binding sites
We hypothesized that the causal variants underlying cis-reQTLs functionally alter the
chromosomal binding sites of transcription factors activated by one or more stimuli. To fine
map reQTLs, we performed a trans-ethnic meta-analysis (28) of imputed variants in each
population (∼10M). We then examined whether the most highly associated meta-reQTLs
overlap with transcription factor (TF)binding sites identified in high-throughput human
ChIP-Seq datasets (e.g., ENCODE) or computationally-predicted conserved regulatory
elements (29-31). We found substantial enrichment (table S7) of known binding sites for
TFs from the STAT family (TFs that are known to be activated downstream of Type I IFN
signaling). The most significant enrichment over background was found for STAT2 (116-
fold, binomial P< 2.55×10−21) and STAT1 (126-fold, binomial P< 2.98×10−13) binding sites
(derived from ChIP-seq in IFNα-stimulated K562 cells) within cis-eQTLs after IFNβ
stimulation.
Among the 57 genes (e.g., SLFN5, CLEC4F, ARL5B; Fig. 3F) with cis-reQTLs in all 3
stimuli, we observed that the most significant cis-reQTL in the: (1 SLFN5 locus
(rs11080327) lies in an ENCODE ChIP-Seq signal (29) for STAT1 (Figs. 4A–C); (2)
CLEC4F locus (rs35856355) alters a commonly occurring cytosine in a canonical ISRE
(interferon-stimulated response element) that is a target of IFN-activated transcription
factors (Figs. 4B and 4C) (22, 30-32); and (3) ARL5B locus (rs2130531) changes a guanine
in the canonical ISRE motif (Figs. 4B and 4C). Additional cis-reQTLs that alter putative
STAT binding sites based on ChIP-Seq data or predicted ISRE motifs include: rs10086852
(PTK2B), rs1981760 (NOD2), rs73023464 (C19ORF12), rs1331717 (IFI44) and rs12064196
(IFI44) (Fig. 4A). Because STAT transcription factors are activated downstream of the type
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I IFN receptor (IFNAR) and bind to ISRE motifs (Fig. 4A) (22), we hypothesized that the
SNPs in these sites are likely causal SNPs within their respective cis-reQTL regions.
cis-reQTLs affect differential binding of stimulus-activated transcription factors
To experimentally validate our predicted regulatory mechanisms, we determined whether
IFNβ-activated transcription factors bind differentially at these SNPs. Using radiolabeled
24-26 bpdsDNA probes in electrophoretic mobility shift assays (EMSA), we found that
probes encompassing the major alleles (rs35856355C and rs2130531G, which are associated
with increased expression in CLEC4F and ARL5B), but not the minor alleles, shifted after
incubation with IFNβ-stimulated MoDC nuclear lysates (Fig. 4D). Consistently, non-
radiolabeled major but not minor allele probes competed for binding to the IFNβ-stimulated
nuclear factors (fig. S4A). By incubating with antibodies to transcription factors known to
bind the ISRE element, we found that IRF1 super-shifted the low MW band and STAT2 and
IRF9 super-shifted the higher MW band, consistent with the known complex of these latter
two proteins (32) (Fig. 4D). These results suggested that the SNPs in CLEC4F and ARL5B
alter the binding of IFN-activated IRF1, STAT2 and IRF9 transcription factors.
To directly test the functional effects of the SNPs, we cloned 150-200 bp genomic regions
surrounding rs11080327 (SLFN5), rs35856355 (CLEC4F) and rs2130531 (ARL5B) upstream
of a luciferase reporter driven by a minimal promoter (Fig. 4E). For each region, we created
two constructs that differ only at the respective SNPs. Since almost all cell types respond to
IFNβ stimulation, we transfected the reporter constructs into HEK-293 cells and stimulated
the cells with IFNβ. Consistent with our hypothesis, the constructs containing the major
alleles of rs11080327 (SLFN5), rs35856355 (CLEC4F) and rs2130531 (ARL5B) induced
respectively 11.6-fold, 2.1-fold and 1.5-fold more luciferase production than the cognate
constructs containing the minor alleles (t-test, P< 0.001, P< 0.001 and P< 0.01, respectively;
Fig. 4E). Furthermore, mutation of motif-conserving nucleotides across the CLEC4F ISRE
motif reduced induction by IFNβ while mutation of non-conserved nucleotides did not (fig.
S4B), consistent with the ISRE consensus motif.
Finally, to further test (33) the functionality of rs11080327 – the SLFN5 variant with the
strongest functional effect –in its native chromosome, we directly edited the genome using
the CRISPR system (34, 35), converting the heterozygous rs11080327A/G in HEK-293 cells
to a homozygous rs11080327G/G (Fig. 4F and fig. S4C). We then stimulated both native and
CRISPR-converted cells with IFNβ. The fold induction of SLFN5 decreased from 3.64 in
heterozygous cells to 1.03 in the converted rs11080327 (G) homozygotes, while the
induction of other genes was unaffected (Fig. 4F and fig. S4C).
The enrichment, EMSA, reporter assays and directed mutagenesis results suggest that we
have identified causal variants in some of these cis-reQTL regions and demonstrate that the
reQTLs occur due to differential binding of stimulus-activated transcription factors.
A cis-eQTL associating with IRF7 is a trans-reQTL
We next attempted to detect cases where variation in gene expression is explained by distant
genetic variants acting in trans. We noted that cis-eQTLs for regulator genes tend to have
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smaller effect sizes and less significant P-values than those for regulated genes (fig. S3E).
To decrease the multiple testing burden of detecting trans associations, we restricted testing
SNPs local to genes on our gene signature set. A number of these are cis-eQTLs associated
with the expression of genes encoding regulators (e.g., transcription factors) in pathways
that we stimulated (Fig. 5A). Of these, rs12805435 was the most significant, associating
with the expression of the master anti-viral transcription factor IRF7 in cis only after
influenza, LPS or IFNβ stimulation(table S4A–D). This SNP associated with both the
expression and induction of 7 additional genes in trans (i.e. the transcriptional start site or
stop codon is located > 1 Mb from the SNP) only after influenza infection: NMI, IFNA4,
IFNA10, IFNA13, IFNA21, IFNA17 and IFNA5 (P <6.26×10−5 in expression, P <1.68×10−5
in differential expression; Fig. 5B and table S8–10).
To test whether the trans-associated genes are indeed targets of IRF7, we infected MoDCs
that overexpressed IRF7 or a control gene with influenza virus, and found that IRF7
overexpression induced the expression of IFNA2, IFNA13 and IFNA14 in influenza-infected
cells (Fig. 5C). In addition, in HEK-293 cells, which normally express very low levels of
IRF7, we overexpressed IRF7 and observed induction of NMI, IFNA4, IFNA10, IFNA13,
IFNA14 and IFNA21 (Fig. 5D), suggesting that IRF7 is sufficient to drive downstream
expression. We have thus identified a stimulus-specific cis-eQTL associated with IRF7
expression, which is also a trans-reQTL that underlies the variability of IFN induction in
response to influenza infection in humans.
reQTLs in DCs overlap with autoimmune and infectious disease SNPs from GWAS
We examined the subset of loci associated in genome-wide association studies (GWAS)
with inflammatory disorders. We first extended an analysis of Crohn's disease in which loci
are enriched for genes specifically expressed in DCs (12, 14) to multiple sclerosis, celiac
disease, psoriasis and leprosy (fig. S5A). We found that genes nearest to the susceptibility
loci for these diseases were not only enriched in DC-specific genes but also in genes induced
by LPS and/or influenza (fig. S5B), suggesting that some of the GWAS loci modulate the
expression of the corresponding genes in activated DCs.
Supporting this hypothesis, 15 cis-reQTLs and 23 cis-eQTLs that were not significant at
baseline but only became significant after stimulation are the same SNPs previously
identified in GWAS of autoimmune and infectious diseases, including Crohn's disease,
multiple sclerosis, celiac disease, psoriasis and leprosy (25) (Figs. 6A, 6B and table S11).
These include: NOD2 with leprosy (rs9302752), IRF7 with systemic lupus erythematosus
(rs4963128), TRAF1 with rheumatoid arthritis (rs881375), and CREM with Crohn's disease
(rs12242110) and ulcerative colitis (rs4246905). For example, rs9302752 – a SNP
previously associated with susceptibility to leprosy (17) – was associated in our study with
expression of NOD2 and its response under IFNβ stimulation (P = 3.49×10−25) but not at
baseline (Fig. 6A and table S11); NOD2 plays a known role in pathogen sensing and
possibly mycobacterial immunity (36). Similarly, rs4963128 – a variant associated with SLE
(37) – was associated in our study with the expression of IRF7 after IFNβ stimulation (P =
1.10×10−16) but not at baseline (Fig. 6A), in line with the importance of type I IFN
responses in SLE pathogenesis (38). We note that rs4963128 is on the same haplotype (R2=
Lee et al. Page 7
Science. Author manuscript; available in PMC 2014 September 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
0.69, D′ = 0.94) as the IRF7 SNP rs12805435 that is associated with the trans-reQTL effect
described above. These results suggest a role for innate immune pathogen-sensing pathways
in the pathogenesis of these inflammatory disorders.
Discussion
While genetic association studies have identified alleles that confer disease risk, little is
known about how these genetic variants contribute to disease through their effects on
specific biological processes and their interaction with environmental stimuli. We addressed
this question by quantifying the dendritic cell response to pathogens in a set of genotyped
individuals, and then leveraged our understanding of these pathways to explain the
mechanisms underlying the observed genotype-environment-phenotype interactions.
Many of the QTL associations we identified are only detectable in the presence of specific
stimuli, underscoring the need to activate cells to capture additional genotype-phenotype
relationships (39-41). Furthermore, few eQTL studies have definitively identified the causal
variants underlying the associations. By measuring variability in hundreds of individuals,
applying stimuli that partially overlap in their downstream pathways, and leveraging
genomic datasets such as the 1000 Genomes Project and ENCODE (29, 42), we (i)
pinpointed causal variants in reQTL regions and (ii) identified the stimulus-activated
transcription factors that bind differentially at these SNPs, explaining some of the GxE
interactions. Our dataset can thus be used to explore mechanisms of GxE interactions (43)
and are consistent with DNaseI-sensitivity QTL (44) and ChIP-Seq QTL (45) studies that
showed that differential transcription factor binding between individuals is pervasive in
resting cells.
The reQTLs we identified provide genetic explanations for inter-individual variation in
innate immune responses. This is best exemplified by the trans-reQTL in the IRF7 locus that
regulates the type I IFN anti-viral response. Our study reveals the effects of this trans-
reQTL on target genes (anti-viral IFN module) in the context of a particular cell type (DCs)
and in response to specific ligands (influenza). The changes in this immune response are, in
turn, likely to impact organismal phenotypes that are driven by the IFN module, including
susceptibility to viral infections and autoimmune diseases like SLE.
Overall, our high-throughput experimental pipeline and integrative analysis of primary
human dendritic cells reveals abundant gene-by-environment interactions, points to the
effects of disease variants on pathogen detection, and motivates extending our approach to a
wide variety of immune cell types and stimulatory conditions to better explain the impact of
human genetic variation on the immune response.
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Fig. 1. A strategy to identify gene-by-environment interactions in the innate immune responses
of primary human dendritic cells
(A) Strategy used to identify baseline and response expression quantitative trait loci (eQTLs
and reQTLs), consisting of five steps: (i) high-throughput isolation and stimulation of
primary human MoDCs from 560 healthy individuals (dotted slices, male; solid-colored
slices, female) collected as part of the PhenoGenetic cohort; (ii) whole-genome gene
expression measurements in a subset of the cohort; (iii) selection of signature gene set,
consisting of regulators and regulated genes; (iv) digital multiplex gene expression
measurements of signature genes in the entire cohort; and (v) mapping of genetic variation
to expression variation. GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-4,
interleukin-4. (B) Model of innate immune pathways activated by three stimuli
demonstrating their downstream relationships. Lipopolysaccharide (“LPS”) from E. coli
engages the TLR4 receptor; interferon-beta (“IFNβ”) engages the heterodimeric IFNAR
receptor; influenza A/PR8 (ΔNS1) (“FLU”) engages the cytoplasmic TLR3 and RIG-I
receptors. Receptor engagement activates signal transduction cascades that regulate
expression of inflammatory genes, IFNs and IFN-stimulated genes. IFNAR activation also
occurs during LPS and FLU stimulations because LPS and FLU both induce IFN
production, leading to activation of ISREs. JAK1, Janus kinase 1.
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Fig. 2. Genome-wide expression profiles in MoDCs reveal response phenotypes
(A) Coefficient of variation (CV) of gene expression between 30 different donors (“Inter-
individual CV”) plotted against CV of expression within 12 serial replicate samples (“Intra-
individual CV”) for each differentially regulated (fold change >0.75 or <–1.5) gene
following LPS or FLU stimulation. Yellow (up-regulated) and purple (down-regulated)
circles represent genes with significant (moderated t test, FDR < 0.1) inter- vs. intra-
individual variation. Right, log2(expression, microarray data) of CLEC4F in baseline, LPS-
stimulated and FLU-infected MoDCs from 30 donors and 12 replicates, demonstrating
example of a gene that shows significant (FDR < 0.01) inter- vs. intra-individual variation
following LPS and FLU stimulations but not at baseline (fig. S2B). Standard error of
replicate samples (n = 12) is shown for each sample. (B) Pie chart of 415 signature genes
selected for Nanostring codeset: 222 (49%) are regulated genes that showed significant
(mixed model variance components test, permutation FDR < 0.1) inter- vs. intra-individual
variability; 61 (14%) are curated, regulated genes with a known function in the innate
immune response; 76 (17%) are curated regulators in the TLR4, TLR3, RIG-I and IFNAR
pathways; 41 (9%) are control genes including low-variance genes, sex-specific genes and
non-expressed genes; 28 (6%) are regulated genes that were reported in the regions of
autoimmune and infectious disease GWAS; and 21 (5%) are regulated genes that showed
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significant inter- versus intra-population variability. (C) Gene expression heatmap of the
415-gene signature in MoDCs from the microarray study (30 individuals) and the
Nanostring study (534 individuals). Each row represents a gene; each column represents a
donor sample at baseline, stimulated with LPS, infected with FLU or stimulated with IFNβ.
Rows were clustered by k-means clustering of Nanostring dataset with major clusters (I, II,
IIIa, IIIb and IV) labeled. Between the two heat maps, each row was labeled with colored
dashes corresponding to one of the 6 categories described in (B).
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Fig. 3. Association analysis reveals cis-eQTLs and cis-reQTLs
(A and B) Manhattan plot of cis-eQTLs (A, baseline expression) and cis-reQTLs (B, LPS-,
FLU- and IFNβ–stimulated fold changes relative to baseline) showing −log10(P values) (left
y axis) and R2 values (right y-axis) for all cis-SNPs, which are displayed on the x-axis with
associated genes ordered by their chromosomal location. (C) Box-whisker plots showing
expression (left; log2(nCounts), y-axis) or fold change (right; log2(fold), y-axis) of DCBLD1,
IFNA21, TEC and ARL5B in resting, LPS-stimulated, FLU-infected and IFNβ–stimulated
MoDCs as a function of genotype of the respective cis-SNPs (x-axis: rs27434, rs10964871,
rs10938526 and rs11015435). African Americans, Asians and Europeans in this order are
displayed as separate box-whisker plots adjacent to each other in each condition. −Log10(P
values) and β statistics are displayed in top right corners. (D and E) Allelic imbalance
analysis of SLFN5 (D) and CLEC4F (E) in resting, LPS-stimulated, FLU-infected and
IFNβ–stimulated MoDCs, showing the ratio of gene expression between the major and
minor alleles in heterozygote (rs11651240 for SLFN5, rs2075221 for CLEC4F) cDNA
samples (n = 8 in (D); n= 9 in (E)) normalized to the ratio in the corresponding genomic
DNA samples; significant deviation from 1.0 (dashed line) is consistent with allelic
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imbalance. Data are from one experiment representative of three (mean and standard
deviation shown). *P< 0.01, **P< 0.001, compared to unstimulated cells (Student's t-test).
On the right panels, box-whisker plots showing expression (left; log2(nCounts), y-axis) or
fold change (right; log2(fold), y-axis) of SLFN5 (D) and CLEC4F (E) in resting, LPS-
stimulated, FLU-infected and IFNβ–stimulated MoDCs as a function of genotype of the
respective cis-SNPs: rs11867191 and rs2075221. (F) Schematic showing the different
combinations of stimuli leading to significant cis-reQTLs, with the most significant
examples listed. Specificity to conditions was defined with M-value >0.9 taken as the
inclusion criteria and M-value <0.1 taken as the exclusion criteria for each condition.
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Fig. 4. Functional fine-mapping and mechanism of cis-reQTLs
(A) Pathway diagram of signal transduction cascade downstream of IFNAR activation.
Activation of receptor leads to downstream activation of JAK-STAT cascade, leading to
posttranslational activation of STAT and IRF transcription factors. (B) LocusZoom plots
showing the −log10(P-values) of imputed cis-eQTLs (y-axis) in the chromosomal regions (x
axis) of SLFN5, CLEC4F and ARL5B. The most significant imputed SNPs in each locus are
labeled. (C) Schematic representation of alleles in the regions near the SLFN5, CLEC4F and
ARL5B genes that are in STAT2 ChIP-Seq binding sites or that perturb ISRE motifs (SNPs
are shown as vertical bars and in red letters). (D) Elecrophoretic mobility shift assays
(EMSA) with 24- to 26-bpradiolabeleddsDNA probes—containing a known ISRE motif
control, a mutated ISRE motif control, the CLEC4F rs35856355 major (C) or minor allele
(A) sequences, or the ARL5B rs2130531 major (G) or minor allele (A) sequences—
incubated with nuclear lysates from IFNβ–stimulated MoDCs. On the right, supershift
assays with or without antibodies against IRF1, IRF9, and STAT2 (designated α-IRF-1, and
so on) with the CLEC4F rs35856355 major (C) probe are shown. (E) Luciferase expression
from reporter constructs transfected into HEK293 cells that were left unstimulated or were
stimulated with 1000 U/mLIFNβ for 21 h. 150–200 bp sequences from the major and minor
haplotypes of the SLFN5, CLEC4F and ARL5B regions were subcloned 5′ of a minimal
promoter and firefly luciferase gene. Firefly luciferase expression was normalized to Renilla
luciferase expression expressed from cotransfected plasmid. (F) Fold change log2(IFNβstim/
unstim) of signature genes in wild-type HEK-293 cells (rs11080327A/G), plotted against fold
change in CRISPR-converted (rs11080327G/G) HEK-293 cells. Data are from one
experiment representative of three (mean and standard shown in (E)). *P< 0.05, **P< 0.01,
compared to unstimulated cells (Student's t-test).
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Fig. 5. Trans-reQTL association at the IRF7 cis-regulatory locus
(A) Diagram showing selected components of TLR4, TLR3, RIG-I and IFNAR pathways.
Components with significant cis-eQTLs (permutation FDR < 0.05) are shown in black (or
red if they also have a trans-eQTL); components that do not have significant cis-eQTLs are
shown in grey. (B) Manhattan plot showing the trans-association of rs12805435 to all 415
genes on signature gene set in baseline, LPS-stimulated, FLU-infected and IFNβ–stimulated
conditions. Trans-reQTL to NMI and cluster of IFNα genes (IFNA4, IFNA10, IFNA13,
IFNA17 and IFNA21) are labeled. (C) Expression (log2(nCounts)) of 415 signature genes in
FLU-infected MoDCs overexpressing IRF7, plotted against expression in FLU-infected
MoDCs overexpressing eGFP control. (D) Expression (log2(nCounts)) of 415 signature
genes in HEK-293 cells overexpressing IRF7, plotted against expression in HEK-293 cells
overexpressing eGFP control. Right, expression of genes in cells with eGFP overexpression
vs. cells without cDNA.
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Fig. 6. Autoimmune and infectious disease–associated SNPs are cis-eQTLs and cis-reQTLs
(A) Expression (log2(nCounts)) of NOD2 in resting and IFNβ–stimulated MoDCs from 184
Caucasians as a function of genotype of the leprosy GWAS SNP, rs9302752 (left). Right,
expression (log2(nCounts)) of IRF7 in resting and IFNβ–stimulated MoDCs from 184
Caucasians as a function of genotype of the SLE GWAS SNP, rs4963128. (B) Plot showing
overlap of genome-wide significant (P< 5×10−8) GWAS SNPs with cis-eQTLs and reQTLs
in MoDCs, with clinical phenotypes connected to corresponding gene expression
phenotypes by lines. Orange circles represent cis-reQTLs (P< 10−7); yellow circles represent
stimulus-specific cis-eQTLs (P< 10−7).
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